fashion -WSS

fashion

author：focus 2025-09-29 20:00:18 - browse：835

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Anthony Fauci pushes back on GOP claims during Covid hearing

hotspot

knowledge

WSS

ASCO Takeaways: Winners, snoozers, and the art of cancer care

STAT wants to know your pick for a great summer read or listen

Climate activists disrupt London Pride march to protest corporate sponsorship

Parkland mass shooting to be reenacted for lawsuit

Eli Lilly’s Zepbound improved liver scarring in mid

UnitedHealth CEO's Medicaid comments send insurer stocks diving

hotspot

fashion

entertainment

Drug repurposing or repositioning? The language matters

ASCO Daily Recap: CAR

At least 13 dead in Texas as scorching temps continue

CMS got Medicare Advantage quality rating wrong, judge rules

The cancer drug shortage isn’t new — and neither are the solutions

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Medicare proposal to cover medical devices draws a mixed reaction

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

explore

Pharma needs to include young adults in clinical research

Data don't support strong claims for Covid

Slain Parkland victim's father speaks out following reenactment

Senators tussle over abortion against the backdrop of a presidential campaign

Data don't support strong claims for Covid

Pediatricians' group reaffirms support for gender

hotspot

hotspot

knowledge

hotspot